false
Catalog
2022 World Conference on Lung Cancer (ePosters)
EP14.05-016. Patterns of Care for Small Cell Lung ...
EP14.05-016. Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study
Back to course
Pdf Summary
A recent study in Victoria, Australia analyzed and reported on the patterns of care for patients newly diagnosed with small cell lung cancer (SCLC). The study included 1006 patients and found that active treatment for SCLC, including chemotherapy, radiotherapy, surgery, and palliative care referrals, was delivered to 89% of patients. Treatment commenced within 14 days of diagnosis in 72% of cases. The median overall survival was 8.9 months, with stage I-III patients having a median survival of 16.3 months and stage IV patients having a median survival of 7.2 months. Better performance status, discussion at multidisciplinary meetings (MDM), and receipt of multimodality treatment were associated with improved survival.<br /><br />The study also identified several clinical quality indicators that can be used to benchmark the quality of cancer care for SCLC. These include documentation of staging, MDM discussions, and supportive care screening. The study showed that these indicators were not consistently met, indicating areas for improvement in the care of SCLC patients.<br /><br />Overall, the study found that active treatment for SCLC in Victoria is high, and survival outcomes are comparable to international series. However, there is room for improvement in terms of treatment timeliness and adherence to clinical quality indicators. The study suggests that improving these areas, as well as engaging patient experience and outcome measures, may be beneficial for enhancing patient care for SCLC.
Asset Subtitle
Robert Stirling
Meta Tag
Speaker
Robert Stirling
Topic
Small Cell Lung Cancer and Neuro-endocrine Tumours - RW/SOC
Keywords
Victoria, Australia
small cell lung cancer
patterns of care
chemotherapy
radiotherapy
surgery
palliative care referrals
treatment commencement
overall survival
performance status
×
Please select your language
1
English